The Lancet Microbe in conversation with

Michael Otto on using probiotics to reduce Staphylococcus aureus

The Lancet Microbe

Rebecca Barksby of The Lancet Microbe talks to Dr Michael Otto and his and his collaborators’ placebo-controlled phase 2 trial that used the probiotic Bacillus subtilis to reduce Staphylococcus aureus in adults who were colonised by the bacteria in the Songkhla region of Thailand.

Read the full article:
Probiotic for pathogen-specific Staphylococcus aureus decolonisation in Thailand

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv